← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-6643 | 71139-6643-1 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-975 | 69194-975-10 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3720 | 72682-3720-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5007 | 70168-5007-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:314 | 314 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-154 | 73177-154-28 | Ketamine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:314 | 314 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:314 | 314 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dextrose | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:314 | 314 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:314 | 314 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexmedetomidine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:314 | 314 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-004 | 79926-004-01 | Cyclosporine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-105 | 73702-105-10 | Esmolol Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-455 | 70092-455-46 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:314 | 314 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-164 | 73177-164-03 | Epinephrine Bitartrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:314 | 314 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5004 | 70168-5004-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:315 | 315 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9228 | 71266-9228-1 | Fentanyl and Bupivacaine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:315 | 315 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:315 | 315 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dextrose | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6054 | 72196-6054-1 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-639 | 72833-639-30 | Dexpanthenol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:315 | 315 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:315 | 315 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine; Tacrolimus | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2207 | 72627-2207-9 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-167 | 73177-167-03 | Epinephrine Bitartrate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3010 | 79559-3010-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:315 | 315 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3010 | 79559-3010-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:316 | 316 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-330 | 69374-330-05 | Albuterol Sulfate 0.5% | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:316 | 316 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-953 | 69374-953-50 | Dextrose Monohydrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6055 | 72196-6055-1 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2412 | 72627-2412-1 | Dexpanthenol | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:316 | 316 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:316 | 316 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine; Tacrolimus | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3725 | 72682-3725-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:316 | 316 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:316 | 316 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0035 | 81483-0035-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0020 | 73271-0020-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-101 | 69761-101-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:316 | 316 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3025 | 79559-3025-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:317 | 317 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | ESTRADIOL 25 PEL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:317 | 317 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0431 | 71285-0431-1 | Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:317 | 317 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dextrose | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:317 | 317 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3129 | 72627-3129-1 | Dapsone; Niacinamide | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3710 | 72682-3710-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:317 | 317 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:317 | 317 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0038 | 81483-0038-0 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0022 | 73271-0022-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-151 | 69761-151-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:317 | 317 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:318 | 318 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5324 | 26436-5324-1 | LIDOCAINE/TETRACAINE 23%/7% | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-703 | 69623-703-37 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:318 | 318 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diazepam | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6054 | 71285-6054-1 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-953 | 69374-953-50 | Dextrose Monohydrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:318 | 318 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:318 | 318 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Demecarium Bromide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3718 | 72682-3718-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:318 | 318 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-165 | 73177-165-03 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-201 | 69761-201-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:318 | 318 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:319 | 319 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:319 | 319 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-965 | 69374-965-02 | Diazepam | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6055 | 71285-6055-1 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-104 | 73702-104-65 | Dextrose Monohydrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:319 | 319 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:319 | 319 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Demecarium Bromide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3722 | 72682-3722-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:319 | 319 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:319 | 319 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-165 | 73177-165-35 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:319 | 319 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:320 | 320 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine PF 1 mg/ml in 30ml NS- 35 ml MB | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:320 | 320 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-965 | 69374-965-32 | Diazepam | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-997 | 69374-997-12 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:320 | 320 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dibasic Potassium Phosphate; Monobasic Potassium Phosphate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:320 | 320 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-011 | 79926-011-02 | Demecarium Bromide | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3706 | 72682-3706-1 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:320 | 320 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-455 | 70092-455-46 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0037 | 81483-0037-0 | Epinephrine Bitartrate; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5619 | 26436-5619-3 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0375 | 73271-0375-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:320 | 320 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0025 | 73271-0025-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:321 | 321 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate Monohydrate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:321 | 321 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:321 | 321 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1012 | 71283-1012-5 | Dimethyl Sulfoxide; Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:321 | 321 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:321 | 321 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-012 | 79926-012-02 | Demecarium Bromide | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2205 | 72627-2205-9 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-977 | 69194-977-10 | Epinephrine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-477 | 70092-477-44 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-371 | 73693-371-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:321 | 321 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0375 | 73271-0375-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:322 | 322 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-365 | 73693-365-01 | TESTOSTERONE, TRIAMCINOLONE 50MG,10MCG | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:322 | 322 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:322 | 322 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7090 | 71285-7090-1 | Diphenhydramine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6054 | 71285-6054-1 | Diltiazem Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:322 | 322 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-114 | 73177-114-15 | Desmopressin Acetate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2206 | 72627-2206-9 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2207 | 72627-2207-9 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-812 | 76154-812-15 | Epinephrine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:322 | 322 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-339 | 83298-339-10 | Epinephrine; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5002 | 70168-5002-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3025 | 79559-3025-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:322 | 322 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0015 | 73271-0015-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:323 | 323 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7423 | 72934-7423-6 | Haxchlo | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:323 | 323 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6054 | 71285-6054-1 | Diltiazem Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7089 | 71285-7089-1 | Diphenhydramine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6055 | 71285-6055-1 | Diltiazem Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:323 | 323 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-014 | 79926-014-03 | Desmopressin Acetate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-144 | 70713-144-01 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2208 | 72627-2208-9 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-813 | 76154-813-15 | Epinephrine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:323 | 323 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5350 | 71139-5350-1 | Epinephrine; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-131 | 70713-131-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5008 | 70168-5008-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-375 | 73693-375-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:323 | 323 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:324 | 324 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-05 | SB-4 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:324 | 324 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Butalbital | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6055 | 71285-6055-1 | Diltiazem Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-5023 | 62295-5023-5 | Diphenhydramine Hydrochloride; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6054 | 72196-6054-1 | Diltiazem Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:324 | 324 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0622 | 5446-0622-01 | Dexamethasone | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-056 | 70713-056-01 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2209 | 72627-2209-9 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-814 | 76154-814-15 | Epinephrine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-11 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5345 | 71139-5345-2 | Epinephrine; Bupivacaine Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5000 | 70168-5000-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-181 | 69761-181-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:324 | 324 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:325 | 325 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8087 | 72682-8087-1 | Testosterone 87.5mg Pellet | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:325 | 325 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcipotriene | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:325 | 325 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:325 | 325 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dipivefrin Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6055 | 72196-6055-1 | Diltiazem Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:325 | 325 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0848 | 5446-0848-01 | Dexamethasone | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-053 | 70713-053-01 | Estradiol | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3025 | 79559-3025-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-106 | 71449-106-15 | Ephedrine Sulfate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-134 | 71449-134-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5001 | 70168-5001-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-061 | 69761-061-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:325 | 325 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:326 | 326 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-251 | 69761-251-01 | Estradiol / Stearic Acid | 2026-1 | valid | 0 | 2026-09-18 |